Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Alopecia areata treatment varies, with no optimal method established yet.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Combining systemic and topical treatments, guided by weekly fungal cultures, effectively treats cat ringworm.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Hair loss in lupus patients indicates higher disease activity.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

PCR-ELISA is better for identifying the fungus causing scalp infections in Ugandan children than traditional methods.

Researchers developed a model that shows hair follicles increase skin absorption of caffeine by 20%.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.